Liquidia jumps as judge criticizes United Therapeutics in patent dispute

Regulation

โดย Seeking Alpha·Read original

Summary · why it matters

Liquidia Corp. rose 8% after a judge criticized United Therapeutics in a long-standing patent dispute. Judge Richard G. Andrews wrote that United Therapeutics failed to explain how changing about ten keystrokes in an 8,500-word original while representing the original is unchanged is anything other than deceptive and backdated. The judge asked United Therapeutics to provide the identity of the lawyer who altered the original interrogatory response. United Therapeutics ticked lower by 1.2%.